Medplus Historical Income Statement

MEDPLUS Stock

750.35 3.50 0.47%

Historical analysis of Medplus Health income statement accounts such as Interest Expense of 721.6 M can show how well Medplus Health Services performed in making a profits. Evaluating Medplus Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Medplus Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Medplus Health Services latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Medplus Health Services is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medplus Health Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Medplus Income Statement Analysis

Medplus Health Services Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Medplus Health shareholders. The income statement also shows Medplus investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Medplus Health Income Statement Chart

At this time, Medplus Health's Tax Provision is comparatively stable compared to the past year. Interest Income is likely to gain to about 335.5 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 1.4 B in 2024.

Selling General Administrative Selling And Marketing Expenses Total Revenue

Total Revenue

Total revenue comprises all receipts Medplus Health Services generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most accounts from Medplus Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Medplus Health Services current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medplus Health Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	1.2B	1.8B	2.2B	1.4B
Interest Income	137.3M	277.9M	319.6M	335.5M

Depreciation And Amortization Interest Income

Medplus Health income statement Correlations

	Tax Provision	Net Interest Income	Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Reconciled Depreciation	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Minority Interest
Tax Provision		0.32	-0.22	-0.24	-0.31	-0.13	-0.37	-0.13	-0.16	-0.15	-0.02	0.22	0.23	-0.24	-0.03	-0.13	-0.22	-0.24	0.47	-0.16	0.23	1.0	0.85
Net Interest Income	0.32		-0.97	-0.9	-0.92	-0.85	-0.36	-0.89	-0.89	-0.9	-0.88	-0.68	-0.74	0.77	-0.87	-0.89	-0.81	-0.9	-0.55	0.83	-0.68	0.32	0.21
Interest Income	-0.22	-0.97		0.93	0.93	0.82	0.41	0.94	0.93	0.94	0.86	0.66	0.75	-0.85	0.9	0.94	0.87	0.93	0.56	-0.81	0.66	-0.22	-0.17
Depreciation And Amortization	-0.24	-0.9	0.93		0.99	0.7	0.34	0.99	1.0	0.99	0.75	0.73	0.8	-0.86	0.96	0.99	0.89	1.0	0.6	-0.75	0.72	-0.24	-0.09
Interest Expense	-0.31	-0.92	0.93	0.99		0.72	0.34	0.98	0.99	0.98	0.76	0.73	0.8	-0.82	0.95	0.98	0.87	0.99	0.59	-0.76	0.73	-0.31	-0.13
Selling General Administrative	-0.13	-0.85	0.82	0.7	0.72		-0.11	0.72	0.7	0.69	0.99	0.44	0.55	-0.6	0.66	0.72	0.44	0.7	0.38	-0.9	0.43	-0.13	-0.24
Selling And Marketing Expenses	-0.37	-0.36	0.41	0.34	0.34	-0.11		0.31	0.33	0.38	-0.06	0.28	0.23	-0.32	0.31	0.3	0.69	0.34	0.16	0.09	0.27	-0.37	-0.12
Total Revenue	-0.13	-0.89	0.94	0.99	0.98	0.72	0.31		1.0	1.0	0.78	0.77	0.85	-0.9	0.98	1.0	0.88	0.99	0.66	-0.8	0.76	-0.13	0.0
Gross Profit	-0.16	-0.89	0.93	1.0	0.99	0.7	0.33	1.0		1.0	0.76	0.78	0.85	-0.9	0.98	1.0	0.9	1.0	0.67	-0.78	0.77	-0.16	-0.01
Other Operating Expenses	-0.15	-0.9	0.94	0.99	0.98	0.69	0.38	1.0	1.0		0.75	0.77	0.85	-0.91	0.98	1.0	0.91	0.99	0.66	-0.77	0.77	-0.15	0.0
Operating Income	-0.02	-0.88	0.86	0.75	0.76	0.99	-0.06	0.78	0.76	0.75		0.57	0.67	-0.71	0.75	0.79	0.52	0.75	0.53	-0.96	0.56	-0.02	-0.09
Net Income From Continuing Ops	0.22	-0.68	0.66	0.73	0.73	0.44	0.28	0.77	0.78	0.77	0.57		0.98	-0.86	0.88	0.76	0.74	0.72	0.97	-0.74	1.0	0.22	0.51
Ebit	0.23	-0.74	0.75	0.8	0.8	0.55	0.23	0.85	0.85	0.85	0.67	0.98		-0.93	0.94	0.84	0.77	0.8	0.96	-0.82	0.98	0.23	0.46
Research Development	-0.24	0.77	-0.85	-0.86	-0.82	-0.6	-0.32	-0.9	-0.9	-0.91	-0.71	-0.86	-0.93		-0.94	-0.9	-0.85	-0.86	-0.85	0.8	-0.86	-0.24	-0.32
Ebitda	-0.03	-0.87	0.9	0.96	0.95	0.66	0.31	0.98	0.98	0.98	0.75	0.88	0.94	-0.94		0.97	0.88	0.96	0.8	-0.82	0.88	-0.03	0.16
Cost Of Revenue	-0.13	-0.89	0.94	0.99	0.98	0.72	0.3	1.0	1.0	1.0	0.79	0.76	0.84	-0.9	0.97		0.87	0.99	0.66	-0.8	0.76	-0.13	0.0
Total Operating Expenses	-0.22	-0.81	0.87	0.89	0.87	0.44	0.69	0.88	0.9	0.91	0.52	0.74	0.77	-0.85	0.88	0.87		0.89	0.62	-0.54	0.74	-0.22	-0.01
Reconciled Depreciation	-0.24	-0.9	0.93	1.0	0.99	0.7	0.34	0.99	1.0	0.99	0.75	0.72	0.8	-0.86	0.96	0.99	0.89		0.6	-0.75	0.72	-0.24	-0.1
Income Before Tax	0.47	-0.55	0.56	0.6	0.59	0.38	0.16	0.66	0.67	0.66	0.53	0.97	0.96	-0.85	0.8	0.66	0.62	0.6		-0.73	0.97	0.47	0.68
Total Other Income Expense Net	-0.16	0.83	-0.81	-0.75	-0.76	-0.9	0.09	-0.8	-0.78	-0.77	-0.96	-0.74	-0.82	0.8	-0.82	-0.8	-0.54	-0.75	-0.73		-0.74	-0.16	-0.18
Net Income	0.23	-0.68	0.66	0.72	0.73	0.43	0.27	0.76	0.77	0.77	0.56	1.0	0.98	-0.86	0.88	0.76	0.74	0.72	0.97	-0.74		0.23	0.52
Income Tax Expense	1.0	0.32	-0.22	-0.24	-0.31	-0.13	-0.37	-0.13	-0.16	-0.15	-0.02	0.22	0.23	-0.24	-0.03	-0.13	-0.22	-0.24	0.47	-0.16	0.23		0.85
Minority Interest	0.85	0.21	-0.17	-0.09	-0.13	-0.24	-0.12	0.0	-0.01	0.0	-0.09	0.51	0.46	-0.32	0.16	0.0	-0.01	-0.1	0.68	-0.18	0.52	0.85

Click cells to compare fundamentals

Medplus Health Account Relationship Matchups

Medplus Health income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Tax Provision	275.7M	319.9M	232.3M	(29.4M)	78.7M	131.4M
Net Interest Income	(382.0M)	(470.5M)	(664.3M)	(830.3M)	(964.3M)	(1.0B)
Interest Income	86M	78M	137.3M	277.9M	319.6M	335.5M
Depreciation And Amortization	748.1M	882.7M	1.2B	1.8B	2.2B	1.4B
Interest Expense	460.7M	536.2M	664.3M	830.3M	964.3M	721.6M
Selling General Administrative	109.4M	141.6M	168.8M	209.5M	6.3B	6.6B
Selling And Marketing Expenses	377.2M	292.7M	473.5M	677.6M	252.1M	444.6M
Total Revenue	28.5B	30.5B	37.6B	45.6B	56.2B	40.5B
Gross Profit	5.1B	6.3B	7.7B	10.0B	12.1B	8.3B
Other Operating Expenses	27.6B	29.2B	36.0B	44.7B	50.6B	38.5B
Operating Income	967.8M	1.4B	1.6B	960.9M	5.6B	5.9B
Net Income From Continuing Ops	17.9M	631.1M	947.2M	501.1M	655.8M	526.6M
Ebit	761.6M	1.5B	1.8B	1.3B	1.7B	1.4B
Ebitda	1.5B	2.4B	3.0B	3.1B	3.9B	2.8B
Cost Of Revenue	23.4B	24.3B	29.8B	35.6B	44.1B	32.2B
Total Operating Expenses	4.2B	5.0B	6.2B	9.2B	6.5B	6.3B
Reconciled Depreciation	748.1M	883.4M	1.2B	1.8B	2.2B	1.4B
Income Before Tax	293.6M	951.0M	1.2B	471.6M	734.4M	707.2M
Total Other Income Expense Net	(623.2M)	(2.0B)	(2.7B)	(489.3M)	(4.9B)	(4.7B)
Net Income	21.8M	638.6M	958.0M	497.6M	654.7M	529.8M
Income Tax Expense	275.7M	319.9M	232.3M	(29.4M)	78.7M	131.4M
Minority Interest	3.9M	7.5M	10.9M	(3.4M)	(1.0M)	(988K)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Medplus Stock Analysis

When running Medplus Health's price analysis, check to measure Medplus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medplus Health is operating at the current time. Most of Medplus Health's value examination focuses on studying past and present price action to predict the probability of Medplus Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medplus Health's price. Additionally, you may evaluate how the addition of Medplus Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medplus Historical Income Statement

About Medplus Income Statement Analysis

Medplus Health Income Statement Chart

Total Revenue

Medplus Health income statement Correlations

Medplus Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Medplus Health income statement Accounts

Also Currently Popular

Additional Tools for Medplus Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Income Tax Expense	+ 1.0	Tax Provision
Gross Profit	+ 1.0	Depreciation And Amortization
Reconciled Depreciation	+ 1.0	Depreciation And Amortization
Gross Profit	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue

Interest Income	- 0.97	Net Interest Income
Total Other Income Expense Net	- 0.96	Operating Income
Ebitda	- 0.94	Research Development
Research Development	- 0.93	Ebit
Interest Expense	- 0.92	Net Interest Income
Research Development	- 0.91	Other Operating Expenses